DOCSLIB.ORG

Coleman Street Investments

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text

Load more

COLEMAN STREET INVESTMENTS A Luxembourg domiciled Open-Ended Investment Fund With multiple sub-funds Semi-Annual Unaudited Report As of 30th June 2020 Luxembourg Corporate and Trade Register RCS No B175 811 No subscriptions can be made on the basis of this Annual Report including audited Financial Statements. Subscriptions are only valid if they are made on the basis of the latest prospectus accompanied by the last Annual Report including Audited Financial Statements and the last unaudited semi-annual Report, if the latter is more recent than the Annual Report including audited Financial Statements. The subscription, conversion and repurchasing forms can be obtained on request addressed to the Registered Office of the Company at 287, Route d’Arlon, L-1150 Luxembourg, G.D.L. 1 | COLEMAN STREET INVESTMENTS TABLE OF CONTENTS ORGANISATION AND ADMINISTRATION ................................................................................................................................................. 3 STATEMENT OF NET ASSETS .................................................................................................................................................................. 6 STATEMENT OF OPERATIONS AND CHANGES IN THE NET ASSETS .................................................................................................. 7 STATEMENT OF CHANGES IN THE NUMBER OF SHARES OUTSTANDING .......................................................................................... 8 STATISTICS ............................................................................................................................................................................................... 9 STATEMENT OF INVESTMENTS AND OTHER NET ASSETS COLEMAN STREET INVESTMENTS - INCOME & GROWTH PORTFOLIO ............................................................................................................................................................................................. 11 STATEMENT OF INVESTMENTS AND OTHER NET ASSETS COLEMAN STREET INVESTMENTS - GROWTH PORTFOLIO ............................................................................................................................................................................................. 14 STATEMENT OF INVESTMENTS AND OTHER NET ASSETS COLEMAN STREET INVESTMENTS - INCOME PORTFOLIO ............. 16 NOTES TO THE FINANCIAL STATEMENTS ............................................................................................................................................ 18 As at ......................................................................................................................................................................................................... 18 COLEMAN STREET INVESTMENTS - ..................................................................................................................................................... 18 COLEMAN STREET INVESTMENTS - ..................................................................................................................................................... 18 2 | COLEMAN STREET INVESTMENTS ORGANISATION AND ADMINISTRATION Registered Office of the Company: 287, route d’Arlon L-1150 LUXEMBOURG Board of Directors of the Company: Frank REARDON Head of Investment Administration JM Finn & Co 4, Coleman Street GB – EC2R 5TA LONDON Director Serge CAMMAERT Director Delen Private Bank Luxembourg S.A. 287, route d’Arlon L-1150 LUXEMBOURG Chairman Daniel VAN HOVE Independant Director Luxembourg 387, route de Longwy L-1940 LUXEMBOURG Director Management Company: CADELUX S.A. 287, route d'Arlon, L-1150 LUXEMBOURG Board of Directors of the Management Company: Chris BRUYNSEELS Administrateur-délégué Capfi Delen Asset Management 178, Jan Van Rijskwijcklaan B-2020 ANTWERPEN Administrator Yves LAHAYE Independant administrator 27, rue des Jacques, B-4360 OREYE Belgium Antonio CALVISI Independant administrator (Until 15/04/2020) 15, cité de Ledenbierg L-5341 MOUTFORT Daniel VAN HOVE Managing Director of Orionis Management S.A. Independant administrator (From 15/04/2020) 387, route de Longwy L-1940 Luxembourg 3 | COLEMAN STREET INVESTMENTS ORGANISATION AND ADMINISTRATION (continued) Conducting officers of the Management Company: Philippe PEIFFER Director, CADELUX S.A. 287, route d'Arlon, L-1150 LUXEMBOURG Gilles WERA Director, CADELUX S.A. 287, route d'Arlon, L-1150 LUXEMBOURG Pierre KEMPENEER Director, CADELUX S.A. 287, route d'Arlon, L-1150 LUXEMBOURG Investment Manager: JM Finn & Co 4, Coleman Street, GB- EC2R 5TA LONDON Depositary Bank and Principal Paying Agent: Delen Private Bank Luxembourg S.A. 287, route d’Arlon L-1150 LUXEMBOURG Administrative, Corporate and Domiciliary Agent: Delen Private Bank Luxembourg S.A. 287, route d’Arlon L-1150 LUXEMBOURG Registrar and Transfer Agent: Delen Private Bank Luxembourg S.A. 287, route d’Arlon L-1150 LUXEMBOURG 4 | COLEMAN STREET INVESTMENTS ORGANISATION AND ADMINISTRATION (continued) Cabinet de revision agréé Deloitte Audit Société à responsabilité limitée 20, Boulevard de Kockelscheuer L-1821 LUXEMBOURG (Until 15/04/2020) EY Luxembourg 35 E, Avenue John F. Kennedy L-1855 LUXEMBOURG (From 15/04/2020) Legal Advisers Elvinger Hoss Prussen 2, place Winston Churchill L-2014 LUXEMBOURG Risk Manager CAPFI DELEN ASSET MANAGEMENT N.V. 184, J. Van Rijswijcklaan B-2020 ANTWERPEN 5 | COLEMAN STREET INVESTMENTS 6 | COLEMAN STREET INVESTMENTS STATEMENT OF NET ASSETS As at 30th June, 2020 COLEMAN STREET COLEMAN STREET COLEMAN STREET INVESTMENTS - NOTE INVESTMENTS - GROWTH INVESTMENTS - INCOME CONSOLIDATED GBP INCOME & GROWTH PORTFOLIO GBP Column1 PORTFOLIO GBP PORTFOLIO GBP ASSETS Investments in securities at acquisition cost 27.062.728,93 23.686.402,23 8.134.904,97 58.884.036,13 Net unrealised gain on investments 4.018.114,28 4.569.158,26 798.428,82 9.385.701,36 Investments in securities at market value 2 31.080.843,21 28.255.560,49 8.933.333,79 68.269.737,49 Cash at bank 2.131.316,03 1.994.943,86 295.555,88 4.221.815,77 Dividends and interest receivable 78.733,89 44.942,52 24.868,11 148.544,52 Receivable on shares suscriptions - - - - TOTAL ASSETS 33.290.893,13 30.295.446,87 9.253.757,78 72.648.097,78 LIABILITIES Other liabilities (94.397,72) (78.069,52) (28.163,32) (200.630,56) Payable on shares redeemed - - - - TOTAL LIABILITIES (94.397,72) (78.069,52) (28.163,32) (200.630,56) TOTAL NET ASSETS AS AT JUNE 30th 2020 33.196.495,41 30.217.377,35 9.225.594,46 72.639.467,22 The accompanying notes form an integral part of these financial statements 7 | COLEMAN STREET INVESTMENTS STATEMENT OF OPERATIONS AND CHANGES IN THE NET ASSETS For the period ended 30th June, 2020 COLEMAN STREET COLEMAN STREET COLEMAN STREET INVESTMENTS - INVESTMENTS - INVESTMENTS - CONSOLIDATED Column1 NOTE INCOME & GROWTH GROWTH INCOME PORTFOLIO (GBP) PORTFOLIO (GBP) PORTFOLIO (GBP) (GBP) Income Bond interest 2 31.411,69 474,57 11.824,83 43.711,09 Dividends (net) 2 301.691,59 215.862,54 115.092,86 632.646,99 Other Income - - - - Total Income 333.103,28 216.337,11 126.917,69 676.358,08 Expenses Investment Management fees 6 (143.124,02) (120.259,86) (36.750,76) (300.134,64) Management Company fees and Risk Management Fees 5 (3.601,14) (3.601,39) (3.601,52) (10.804,05) Administrative and Depositary fees 4 (15.527,05) (13.065,96) (4.459,92) (33.052,93) Audit and supervisory fees (4.125,88) (4.125,88) (4.125,66) (12.377,42) Subscription tax 7 (7.510,31) (6.528,27) (2.094,21) (16.132,79) Other expenses (46.740,96) (56.809,61) (11.991,26) (115.541,83) Total Expenses (220.629,36) (204.390,97) (63.023,33) (488.043,66) Net gain on investments 112.473,92 11.946,14 63.894,36 188.314,42 Net realised gain/(loss) on sales of investments and currency 2 493.331,04 398.466,65 68.347,14 960.144,83 Net gain realised 605.804,96 410.412,79 132.241,50 1.148.459,25 Change in unrealised appreciation (/depreciation) on the investments (2.026.968,42) (1.137.196,84) (733.950,64) (3.898.115,90) Net increase (/decrease ) in net assets as a result of operations (1.421.163,46) (726.784,05) (601.709,14) (2.749.656,65) Shares subscriptions 2.839.889,89 5.559.391,50 395.507,16 8.794.788,55 Shares redemptions (1.577.009,14) (1.477.790,54) (494.325,82) (3.549.125,50) Net subscriptions 1.262.880,75 4.081.600,96 (98.818,66) 5.245.663,05 Dividend distributed 10 (230.013,12) (41,93) (71.278,87) (301.333,92) Net assets at the beginning of the period 33.584.791,24 26.862.602,37 9.997.401,13 70.444.794,74 Net assets at the end of the period 33.196.495,41 30.217.377,35 9.225.594,46 72.639.467,22 The accompanying notes form an integral part of these financial statements 8 | COLEMAN STREET INVESTMENTS STATEMENT OF CHANGES IN THE NUMBER OF SHARES OUTSTANDING Number of outstanding Number of subscribed Number of redeemed Number of outstanding ISIN Share class shares as of 31/12/2019 shares shares shares as of 30/06/2020 COLEMAN STREET INVESTMENT-INCOME & GROWTH PORTFOLIO LU0904707105 Accumulation shares A 7.078.148,98 953.192,88 663.104,83 7.368.237,03 COLEMAN STREET INVESTMENT-INCOME & GROWTH PORTFOLIO LU0904707444 Distribution shares A 13.753.310,50 1.119.760,17 587.611,59 14.285.459,08 COLEMAN STREET INVESTMENT-INCOME & GROWTH PORTFOLIO LU0904707956 Accumulation shares C 784.997,14 31.137,56 41.524,79 774.609,91 COLEMAN STREET INVESTMENT-INCOME & GROWTH PORTFOLIO LU0904708095 Distribution shares C 916.686,70 200.000,00 1.116.686,70 COLEMAN STREET INVESTMENT-INCOME & GROWTH PORTFOLIO LU0904708178 Accumulation shares 1 1.000,00 1.000,00 COLEMAN STREET
Recommended publications
  • Annual Report and Accounts 2014 3FOJTIBXQMD Annual Report and Accounts 2014

    Annual Report and Accounts 2014 3FOJTIBXQMD Annual Report and Accounts 2014

    Annual report and accounts 2014 3FOJTIBXQMD Annual report and accounts 2014 Contents 4USBUFHJDSFQPSU (PWFSOBODF 'JOBODJBMTUBUFNFOUT *OUSPEVDUJPO *OUSPEVDUJPO $POTPMJEBUFEJODPNFTUBUFNFOU $IBJSNBOTTUBUFNFOU #PBSEPGEJSFDUPSTBOEDPNQBOZTFDSFUBSZ $POTPMJEBUFECBMBODFTIFFU 0VSCVTJOFTTNPEFM &YFDVUJWF#PBSE $POTPMJEBUFETUBUFNFOU 0VSTUSBUFHZ *OUFSOBUJPOBM4BMFTBOE.BSLFUJOH#PBSE PGDPNQSFIFOTJWFJODPNF BOEFYQFOTF 0VSTUSBUFHZJOBDUJPO %JSFDUPSTDPSQPSBUFHPWFSOBODFSFQPSU $POTPMJEBUFETUBUFNFOUPGDIBOHFTJOFRVJUZ 0VSCVTJOFTTTFDUPSTm.FUSPMPHZ /PNJOBUJPODPNNJUUFFSFQPSU $POTPMJEBUFETUBUFNFOUPGDBTh flPX 4QBUJBMNFBTVSFNFOUEFWJDFTPWFSWJFX "VEJUDPNNJUUFFSFQPSU /PUFTUPUIFDPOTPMJEBUFE 0VSCVTJOFTTTFDUPSTm)FBMUIDBSF %JSFDUPSTSFNVOFSBUJPOSFQPSU fiOBODJBMTUBUFNFOUT 0VSNBSLFUTm%FMJWFSJOHTPMVUJPOTHMPCBMMZ 0UIFSTUBUVUPSZBOESFHVMBUPSZEJTDMPTVSFT $PNQBOZCBMBODFTIFFU 1FSGPSNBODFm0WFSWJFX %JSFDUPSTSFTQPOTJCJMJUJFT 3FDPODJMJBUJPOPGNPWFNFOUT 1FSGPSNBODFm.FUSPMPHZ *OEFQFOEFOUBVEJUPSTSFQPSUUPUIF JOTIBSFIPMEFSTGVOET 1FSGPSNBODFm.BOVGBDUVSJOH NFNCFSs oG3FOJTIBXQMD /PUFTUPUIF$PNQBOy fiOBODJBMTUBUFNFOUT 1FSGPSNBODFm)FBMUIDBSF 1FSGPSNBODFm'JOBODJBMSFWJFX 4IBSFIPMEFSJOGPSNBUJPO ,FZQFSGPSNBODFJOEJDBUPST 1SJODJQBMSJTLTBOEVODFSUBJOUJFT ZFBr fiOBODJBMSFDPSE $PSQPSBUFTPDJBMSFTQPOTJCJMJUZ 4VCTJEJBSZVOEFSUBLJOHT 4IBSFIPMEFSJOGPSNBUJPO 1 3FOJTIBXQMD Annual report and accounts 2014 Introduction report Strategic Renishaw is a world leading metrology company. With our highly experienced team, we are confidently driving our future growth through innovative and patented products
  • Description Iresscode Exchange Current Margin New Margin 3I

    Description Iresscode Exchange Current Margin New Margin 3I

    Description IRESSCode Exchange Current Margin New Margin 3I INFRASTRUCTURE PLC 3IN LSE 20 20 888 HOLDINGS PLC 888 LSE 20 20 ASSOCIATED BRITISH ABF LSE 10 10 ADMIRAL GROUP PLC ADM LSE 10 10 AGGREKO PLC AGK LSE 20 20 ASHTEAD GROUP PLC AHT LSE 10 10 ANTOFAGASTA PLC ANTO LSE 15 10 ASOS PLC ASC LSE 20 20 ASHMORE GROUP PLC ASHM LSE 20 20 ABERFORTH SMALLER COM ASL LSE 20 20 AVEVA GROUP PLC AVV LSE 20 20 AVIVA PLC AV LSE 10 10 ASTRAZENECA PLC AZN LSE 10 10 BABCOCK INTERNATIONAL BAB LSE 20 20 BARR PLC BAG LSE 25 20 BARCLAYS PLC BARC LSE 10 10 BRITISH AMERICAN TOBA BATS LSE 10 10 BAE SYSTEMS PLC BA LSE 10 10 BALFOUR BEATTY PLC BBY LSE 20 20 BARRATT DEVELOPMENTS BDEV LSE 10 10 BARING EMERGING EUROP BEE LSE 50 100 BEAZLEY PLC BEZ LSE 20 20 BH GLOBAL LIMITED BHGG LSE 30 100 BOWLEVEN PLC BLVN LSE 60 50 BANKERS INVESTMENT BNKR LSE 20 20 BUNZL PLC BNZL LSE 10 10 BODYCOTE PLC BOY LSE 20 20 BP PLC BP LSE 10 10 BURBERRY GROUP PLC BRBY LSE 10 10 BLACKROCK WORLD MININ BRWM LSE 20 65 BT GROUP PLC BT-A LSE 10 10 BRITVIC PLC BVIC LSE 20 20 BOVIS HOMES GROUP PLC BVS LSE 20 20 BROWN GROUP PLC BWNG LSE 25 20 BELLWAY PLC BWY LSE 20 20 BIG YELLOW GROUP PLC BYG LSE 20 20 CENTRAL ASIA METALS PLC CAML LSE 40 30 CLOSE BROTHERS GROUP CBG LSE 20 20 CARNIVAL PLC CCL LSE 10 10 CENTAMIN PLC CEY LSE 20 20 CHARIOT OIL & GAS LTD CHAR LSE 100 100 CHEMRING GROUP PLC CHG LSE 25 20 CONYGAR INVESTMENT CIC LSE 50 40 CALEDONIA INVESTMENTS CLDN LSE 25 20 CARILLION PLC CLLN LSE 100 100 COMMUNISIS PLC CMS LSE 50 100 CENTRICA PLC CNA LSE 10 10 CAIRN ENERGY PLC CNE LSE 30 30 COBHAM PLC
  • Parker Review

    Parker Review

    Ethnic Diversity Enriching Business Leadership An update report from The Parker Review Sir John Parker The Parker Review Committee 5 February 2020 Principal Sponsor Members of the Steering Committee Chair: Sir John Parker GBE, FREng Co-Chair: David Tyler Contents Members: Dr Doyin Atewologun Sanjay Bhandari Helen Mahy CBE Foreword by Sir John Parker 2 Sir Kenneth Olisa OBE Foreword by the Secretary of State 6 Trevor Phillips OBE Message from EY 8 Tom Shropshire Vision and Mission Statement 10 Yvonne Thompson CBE Professor Susan Vinnicombe CBE Current Profile of FTSE 350 Boards 14 Matthew Percival FRC/Cranfield Research on Ethnic Diversity Reporting 36 Arun Batra OBE Parker Review Recommendations 58 Bilal Raja Kirstie Wright Company Success Stories 62 Closing Word from Sir Jon Thompson 65 Observers Biographies 66 Sanu de Lima, Itiola Durojaiye, Katie Leinweber Appendix — The Directors’ Resource Toolkit 72 Department for Business, Energy & Industrial Strategy Thanks to our contributors during the year and to this report Oliver Cover Alex Diggins Neil Golborne Orla Pettigrew Sonam Patel Zaheer Ahmad MBE Rachel Sadka Simon Feeke Key advisors and contributors to this report: Simon Manterfield Dr Manjari Prashar Dr Fatima Tresh Latika Shah ® At the heart of our success lies the performance 2. Recognising the changes and growing talent of our many great companies, many of them listed pool of ethnically diverse candidates in our in the FTSE 100 and FTSE 250. There is no doubt home and overseas markets which will influence that one reason we have been able to punch recruitment patterns for years to come above our weight as a medium-sized country is the talent and inventiveness of our business leaders Whilst we have made great strides in bringing and our skilled people.
  • ASSET ALLOCATION RISK GRADE Fixed Interest 44.97

    ASSET ALLOCATION RISK GRADE Fixed Interest 44.97

    COMPLETE FINANCIAL SOLUTIONS INTRODUCING THE PARTNERSHIP 02 03 Our Philosophy The Marlborough Funds As our client, you are the one and only Marlborough’s Irish-domiciled fund priority. Our advisors are dedicated to of funds range provides you with providing an unparalleled service that comprehensive risk-graded investment puts you, your needs and your ambitions solutions in a UCITS structure. at the forefront of every stage of They are expertly managed ‘all-in-one’ decision-making. portfolios constructed using a blend Our common aim is to secure a of active and passive funds. We use prosperous future for you and your actively managed funds in areas where family. By combining our expertise with a we believe they can add real value personalised approach to your finances, and select managers with exceptional we can help you to achieve your goals. track records, including those running Marlborough’s award-winning single- Our Commitment strategy funds. We are committed to developing As stablemates in the Marlborough lifelong relationships with our clients Group, we can access the expertise – ones based on integrity, trust and a and resources of these highly respected clear understanding of your personal managers at institutional rates, which circumstances. We believe this is the key helps to keep costs for our investors as to successful financial planning. low as possible. We work exclusively for and with our clients and so all consultations are treated in the strictest confidence between you and your advisor. As our client, you can count on us to keep to our commitment. Fund performance and awards 60 % Marlborough 55 % 50 % CAUTIOUS 45 % Investment Growth 40 % 01/07/2016 to 30/06/2021 35 % Marlborough 38.4% 30 % Cautious Fund Z 25 % Source: Morningstar Direct, mid-mid, 20 % net income reinvested.
  • Annual Report: 2018

    Annual Report: 2018

    Annual report and accounts 2018 Annual Report and Accounts 2018 Renishaw is a world leading metrology company. With our highly experienced team, we are confidently driving our future growth through innovative and patented products and processes, efficient, high-quality manufacturing and the ability to provide local support in our expanding global markets. 95% of our sales are outside the UK. Our continuing investment in new product development, plant and equipment, and facilities (c.£100m in the last year) is the key to our confidence in the Group’s long-term strategy and prospects. With more than 4,800 skilled and motivated people, we are at the leading edge of delivering innovative solutions globally. Financial highlights Strategic reportStrategic Revenue Contents Strategic report £611.5m 0 Introduction (2017: £536.8m) 1 Financial highlights 2 Renishaw at a glance 4 Chairman’s statement Adjusted* profit before tax 6 Chief Executive’s review Governance 10 Our business model 12 Our strategy £145.1m 15 Key performance indicators (2017: £10 9.1m) 16 Our markets 18 Performance – financial review 22 Delivering global solutions Statutory profit before tax 24 Metrology 28 Healthcare 32 Risk and risk management Financial statements £155.2m 34 Principal risks and uncertainties (2017: £117.1m) 38 Corporate social responsibility Dividend per share Governance 44 Directors’ corporate governance report 46 Board of directors 60.0p information Shareholder 48 Executive Board (2017: 52.0p) 49 International Sales and Marketing Board Adjusted* earnings per
  • Virtus Allianzgi International Small-Cap Fund

    Virtus Allianzgi International Small-Cap Fund

    Virtus AllianzGI International Small-Cap Fund as of : 08/31/2021 (Unaudited) SECURITY SHARES TRADED MARKET VALUE % OF PORTFOLIO ASMedia Technology Inc 23,000 $1,722,085 2.04 % Unimicron Technology Corp 319,000 $1,697,819 2.01 % Evotec SE 33,494 $1,664,973 1.97 % Georg Fischer AG 954 $1,565,779 1.85 % Grafton Group PLC 80,693 $1,549,843 1.83 % Elkem ASA 361,810 $1,541,414 1.82 % Genus PLC 18,880 $1,540,558 1.82 % Howden Joinery Group PLC 118,070 $1,534,979 1.82 % Interroll Holding AG 340 $1,511,111 1.79 % Cancom SE 22,963 $1,510,768 1.79 % Spectris PLC 27,520 $1,490,733 1.76 % ASM International NV 3,841 $1,490,287 1.76 % Soitec 6,191 $1,479,549 1.75 % Intermediate Capital Group PLC 48,932 $1,478,686 1.75 % Aperam SA 23,199 $1,423,300 1.68 % Fuji Electric Co Ltd 32,600 $1,411,980 1.67 % Wienerberger AG 35,448 $1,391,268 1.65 % Bechtle AG 19,089 $1,379,858 1.63 % Jungheinrich AG Pref 24,964 $1,348,243 1.60 % Storebrand ASA 151,651 $1,346,924 1.59 % JMDC Inc 19,500 $1,336,454 1.58 % 1 SECURITY SHARES TRADED MARKET VALUE % OF PORTFOLIO Industrial & Infrastructure Fund Investment Corp 653 $1,312,945 1.55 % ValueCommerce Co Ltd 31,900 $1,309,171 1.55 % Jeol Ltd 17,700 $1,308,013 1.55 % Tokyu Fudosan Holdings Corp 225,200 $1,303,935 1.54 % ASR Nederland NV 28,191 $1,288,854 1.53 % Huhtamaki Oyj 24,096 $1,286,286 1.52 % Crest Nicholson Holdings plc 221,947 $1,280,994 1.52 % Aak Ab 53,435 $1,278,063 1.51 % Jenoptik AG 35,252 $1,272,856 1.51 % Auto Trader Group PLC 146,909 $1,270,441 1.50 % Elis SA 71,514 $1,264,914 1.50 % Sojitz Corp 415,100 $1,218,718
  • KPMG Equity Capital Markets H1 2019 Review

    KPMG Equity Capital Markets H1 2019 Review

    MARGIN MARGIN MARGIN CROP MARKS CROP MARGIN CROP MARKS CROP Equity Capital Markets H1 2019 review July 2019 kpmg.com/uk/equitycapitalmarkets CROP MARKS CROP MARGIN CROP MARKS CROP MARGIN MARGIN MARGIN MARGIN MARGIN MARGIN CROP MARKS CROP MARGIN CROP MARKS CROP £19.2 bn funds raised 5% on H1-18 22% on H2-18 £14.8 bn raised via further issues 7% on H1-18 42% on H2-18 £4.4 bn raised via IPOs 4% on H1-18 16% on H2-18 21 IPOs 49% on H1-18 43% on H2-18 UK equity capital markets exhibited resilience in spite of the continued presence of challenging macroeconomic and political conditions during H1 2019 CROP MARKS CROP MARGIN © 2019 KPMG LLP, a UK limited liability partnership and a member firm of the KPMG network of independent member firms affiliated with KPMG International Cooperative (“KPMG International”), a Swiss entity. All rights reserved. CRO RKS MAR MARGIN MARGIN MARGIN MARGIN MARGIN CROP MARKS CROP MARGIN CROP MARKS CROP H1 2019 snapshot Total UK equity fundraising levels remained broadly consistent with recent periods, with placings rebounding from a relative downturn in H2 2018 UK equity issuances H1 2017 to H1 2019 Largest UK IPOs in H1 2019 Funds raised (£bn) 30 Network International Holdings plc £1,218m 25 23.6 20.2 20 19.2 17.5 15.7 Trainline plc £1,093m 15 10 Airtel Africa plc £541m 5 0 H1 H2 H1 H2 H1 2017 2017 2018 2018 2019 IPOs Rights issues Placings IPO numbers, particularly on AIM, remain low, however a number of significant Main Market IPOs in Q2 increased overall funds raised compared to H1 2018 Main Market AIM Funds raised Funds raised (£bn) No.
  • RCP BIA 2020 Review January 2021 FINAL.Pdf

    RCP BIA 2020 Review January 2021 FINAL.Pdf

    UK BioIndustry Association UK Listed Biotech & Life Sciences 2020 – Year in Review– May you live in interesting times Radnor Broad UK Listed Biotech Index - 2 Year Chart Unweighted Weighted FTSE All-Share 350 300 250 200 150 100 50 Dec '20 Dec Dec '18 Dec '19 Mar '19 Jun '19 Sep '19 Dec '20 Mar '20 Jun '20 Sep Source: FactSet, Radnor 2020 has been an extraordinary year across the market but there is no doubt that the UK listed biotech sector has been in the front line in more ways than one. Investors have clearly responded to both the efforts made by the sector to combat the pandemic, but also the structural growth opportunity within biotech that the pandemic has bought into sharper focus. Not only have we seen headline share price underperformance reverse sharply through the course of 2020, but critically, the pace and scale of sector fundraising activity has stepped up materially. Perhaps most importantly, the number of investors active in the sector (institutional, private wealth, individual and overseas) have expanded. This feature alone has gone a long way towards addressing one of the key issues facing the sector. The BioIndustry Association ▪ Sector Outperformance. 2020 has been the strongest period of price is a research client of Radnor outperformance over the last 10 years. Interestingly, this outperformance has Capital Partners Ltd. been delivered across all the sub-indices making up the Broad Biotech index; although performance levels have varied somewhat. This outperformance has MiFID II – this research is also been much more pronounced then looking at the sector on an equal deemed to be a minor, non- monetary benefit.
  • FTSE Russell Publications

    FTSE Russell Publications

    2 FTSE Russell Publications 19 August 2021 FTSE 250 Indicative Index Weight Data as at Closing on 30 June 2021 Index weight Index weight Index weight Constituent Country Constituent Country Constituent Country (%) (%) (%) 3i Infrastructure 0.43 UNITED Bytes Technology Group 0.23 UNITED Edinburgh Investment Trust 0.25 UNITED KINGDOM KINGDOM KINGDOM 4imprint Group 0.18 UNITED C&C Group 0.23 UNITED Edinburgh Worldwide Inv Tst 0.35 UNITED KINGDOM KINGDOM KINGDOM 888 Holdings 0.25 UNITED Cairn Energy 0.17 UNITED Electrocomponents 1.18 UNITED KINGDOM KINGDOM KINGDOM Aberforth Smaller Companies Tst 0.33 UNITED Caledonia Investments 0.25 UNITED Elementis 0.21 UNITED KINGDOM KINGDOM KINGDOM Aggreko 0.51 UNITED Capita 0.15 UNITED Energean 0.21 UNITED KINGDOM KINGDOM KINGDOM Airtel Africa 0.19 UNITED Capital & Counties Properties 0.29 UNITED Essentra 0.23 UNITED KINGDOM KINGDOM KINGDOM AJ Bell 0.31 UNITED Carnival 0.54 UNITED Euromoney Institutional Investor 0.26 UNITED KINGDOM KINGDOM KINGDOM Alliance Trust 0.77 UNITED Centamin 0.27 UNITED European Opportunities Trust 0.19 UNITED KINGDOM KINGDOM KINGDOM Allianz Technology Trust 0.31 UNITED Centrica 0.74 UNITED F&C Investment Trust 1.1 UNITED KINGDOM KINGDOM KINGDOM AO World 0.18 UNITED Chemring Group 0.2 UNITED FDM Group Holdings 0.21 UNITED KINGDOM KINGDOM KINGDOM Apax Global Alpha 0.17 UNITED Chrysalis Investments 0.33 UNITED Ferrexpo 0.3 UNITED KINGDOM KINGDOM KINGDOM Ascential 0.4 UNITED Cineworld Group 0.19 UNITED Fidelity China Special Situations 0.35 UNITED KINGDOM KINGDOM KINGDOM Ashmore
  • UK P&L 161107 MAR.Xlsx

    UK P&L 161107 MAR.Xlsx

    Messels December 2016 Rec Last UK FTSE 100 Stocks Open price Close/last %chg Index Relative 30-Nov 30-Dec BP/ LN Equity BP PLC 459.45 509.6 10.9% 5.29% 5.6% 30-Nov 30-Dec RRS LN Equity Randgold Resources Ltd 5700 6415 12.5% 5.29% 7.3% 30-Nov 30-Dec RIO LN Equity Rio Tinto PLC 2990 3158.5 5.6% 5.29% 0.3% 30-Nov 30-Dec BA/ LN Equity BAE Systems PLC 600.5 591.5 -1.5% 5.29% -6.8% 30-Nov 30-Dec CRH LN Equity CRH PLC 2660 2830 6.4% 5.29% 1.1% 30-Nov 30-Dec CRDA LN Equity Croda International PLC 3262 3196 -2.0% 5.29% -7.3% 30-Nov 30-Dec AHT LN Equity Ashtead Group PLC 1567 1580 0.8% 5.29% -4.5% 30-Nov 30-Dec BNZL LN Equity Bunzl PLC 2060 2109 2.4% 5.29% -2.9% 30-Nov 30-Dec EXPN LN Equity Experian PLC 1510 1574 4.2% 5.29% -1.1% 30-Nov 30-Dec WOS LN Equity Wolseley PLC 4645 4962 6.8% 5.29% 1.5% 30-Nov 30-Dec GSK LN Equity GlaxoSmithKline PLC 1495.5 1562 4.4% 5.29% -0.8% 30-Nov 30-Dec BRBY LN Equity Burberry Group PLC 1429 1497 4.8% 5.29% -0.5% 30-Nov 30-Dec RB/ LN Equity Reckitt Benckiser Group PLC 6763 6886 1.8% 5.29% -3.5% 30-Nov 30-Dec MRW LN Equity Wm Morrison Supermarkets PLC 217.5 230.7 6.1% 5.29% 0.8% 13-Dec 30-Dec ITV LN Equity ITV PLC 192.1 206.4 7.4% 2.50% 4.9% 20-Dec 30-Dec REL LN Equity RELX PLC 1417 1449 2.3% 1.40% 0.9% 30-Nov 30-Dec MCRO LN Equity Micro Focus International PLC 2111 2179 3.2% 5.29% -2.1% 30-Nov 30-Dec BARC LN Equity Barclays PLC 215.95 223.45 3.5% 5.29% -1.8% 06-Dec 30-Dec DLG LN Equity Direct Line Insurance Group PLC 354.8 369.4 4.1% 5.35% -1.2% 30-Nov 30-Dec PRU LN Equity Prudential PLC 1548.5 1627.5 5.1% 5.29% -0.2%
  • Witan Investment Trust Plc Portfolio Listing As at 30.04.2021

    Witan Investment Trust Plc Portfolio Listing As at 30.04.2021

    WITAN INVESTMENT TRUST PLC PORTFOLIO LISTING AS AT 30.04.2021 SECURITY % OF TOTAL INVESTMENT APAX GBL ALPHA NPV 3.04 PRINCESS PRIVATE EQTY HLDGS ORD EUR0.001 2.00 ALPHABET A USD0.001 1.89 SYNCONA ORD NPV 1.50 BLACKROCK WORLD MINING TST ORD GBP0.05 1.42 BT GRP ORD GBP0.05 1.22 CHARTER COMMUNICATIONS -A USD0.001 1.21 DIAGEO GBP28.93518 1.18 ELECTRA PRIVATE EQTY GBP 0.25 1.18 HEINEKEN HLDGS EUR1.6 1.12 PAYPAL HLDGS USD0.0001 1.11 UNILEVER GBP0.031111 1.04 VIVENDI EUR5.5 0.99 ARCELORMITTAL NPV 0.98 SCHRODER REAL ESTATE INV TST ORD NPV 0.98 THERMO FISHER SCIENTIFIC USD1 0.90 WALT DISNEY CO USD0.01 0.88 INTUIT USD0.01 0.87 LLOYDS BANKING GRP GBP0.1 0.87 SMURFIT KAPPA GRP EUR0.001 0.83 VINCI EUR2.5 0.83 FREEPORT-MCMORAN USD0.1 0.83 TAIWAN SEMICONDUCTOR MANUFACTURING 1 ADS REP 5 ORD TWD10 0.82 CANADIAN PACIFIC RAILWAY NPV 0.78 NINTENDO CO NPV 0.77 RELX GBP0.144397 0.77 LONDON STK EXCHANGE GRP GBP0.06918605 0.76 TESCO GBP0.0633333 0.75 NATWEST GRP GBP1 0.75 BARCLAYS GBP0.25 0.74 FLUTTER ENT GBP0.09 0.74 UNITEDHEALTH GRP USD0.01 0.73 NATL GRID ORD GBP0.12431289 0.73 FACEBOOK A USD0.000006 0.72 MONDELEZ INTL USD0.01 0.72 MICROSOFT CORP USD0.00000625 0.71 BAE SYSTEMS ORD GBP0.025 0.71 SHISEIDO CO NPV 0.70 FISERV USD0.01 0.69 VH GBL SUSTAINABLE ENERGY NPV 0.69 PEPSICO USD0.017 0.69 TENCENT HLDGS HKD0.00002 0.68 SAFRAN EUR0.20 0.67 MERCADOLIBRE COM USD0.001 0.66 PEARSON GBP0.25 0.66 CRH EUR0.32 0.64 LVMH MOET HENNESSY LOUIS VUI EUR0.3 0.64 BAXTER INTL COM USD1 0.62 COOPER COS COM USD0.10 0.62 MASTERCARD A USD0.0001 0.62 BREEDON GRP NPV 0.61 SHOPIFY
  • Annual Report and Accounts for the Year Ended 31 December 2010

    Annual Report and Accounts for the Year Ended 31 December 2010

    Hill & Smith Holdings PLC Hill & Smith Holdings PLC 2010 Annual Report and Accounts for the Westhaven House, year ended 31 December 2010 Arleston Way, Shirley, Solihull, B90 4LH Tel: +44 (0) 121 704 7430 Fax: + 44 (0) 121 704 7439 Hill & Smith Holdings PLC Annual Report and Accounts 2010 www.hsholdings.com 20073-04 Hill&Smith_AW_CVR.indd 1 18/03/2011 16:32:05 Hill & Smith Holdings PLC Hill & Smith Holdings PLC Annual Report and Accounts 2010 Annual Report and Accounts 2010 10 Hill & Smith Holdings PLC Hill & Smith Holdings PLC is an international group with leading positions in the supply to global markets of infrastructure products, galvanizing services and building and construction products. It serves its customers from facilities principally in the UK, France, USA, Thailand and China. A fire escape galvanized by France Galva for the Système U retail group head office in France. Contents Overview 01 Key Financial Highlights 02 Chairman’s Statement Review of 2010 04 Business Review 10 Our Divisions 13 Key Performance Indicators 14 Principal Risks and Uncertainties 16 Key Resources and Contractual Relationships 18 Corporate Social Responsibility Governance 24 Board of Directors and Biographies 26 Directors’ Report 30 Corporate Governance Report 35 Directors’ Remuneration Report 42 Statement of Directors’ Responsibilities Financial Statements 43 Independent Auditor’s Report 44 Group Financial Statements 82 Company Financial Statements 90 Five Year Summary and Financial Calendar Information 91 Shareholder Information 92 Principal Group Businesses 94 Directors, Contacts and Professional Advisers 96 Notes Front Cover in descending order V&S LLC’s galvanized welded studs on 64’ beams for the Tappanzee Bridge in New York.